Enhanced molecular mimicry of CEA using photoaffinity crosslinked C3d peptide
- 1 May 1998
- journal article
- research article
- Published by Springer Nature in Nature Biotechnology
- Vol. 16 (5) , 458-462
- https://doi.org/10.1038/nbt0598-458
Abstract
Antigen mimicry of using anti-idiotypic antibodies for use as cancer vaccines has been disappointing due to the weak immunogenicity of immunoglobulin variable domains. To enhance the immunogenicity of an anti-idiotype vaccine we incorporated a molecular adjuvant peptide into the antibody. The peptide is derived from the C3d region known to bind CR2 receptors on B-cells. A photoreactive peptide is synthesized that affinity-labels a single site in the antibody variable domain. The molecular adjuvant peptide is crosslinked to the anti-idiotype mimetic by chemical means without modifying other sites on the antibody. The C3d-conjugated anti-idiotype antibody induces a strong idiotype and antigen-specific response in mice.Keywords
This publication has 26 references indexed in Scilit:
- C3d of Complement as a Molecular Adjuvant: Bridging Innate and Acquired ImmunityScience, 1996
- Preclinical Evaluation in Nonhuman Primates of an Anti-Idiotypic Antibody that Mimicks the Carcinoembryonic AntigenJournal of Immunotherapy, 1995
- Impairment of T-cell-dependent B-cell responses and B-l cell development in CD19-deficient miceNature, 1995
- The CD19/CR2/TAPA-1 Complex of B Lymphocytes: Linking Natural to Acquired ImmunityAnnual Review of Immunology, 1995
- The CD19/CR2/TAPA-1 Complex of B Lymphocytes: Linking Natural To Acquired ImmunityAnnual Review of Immunology, 1995
- Clinical outcome of colorectal cancer patients treated with human monoclonal anti‐idiotypic antibodyInternational Journal of Cancer, 1994
- Idiotypic antibody immunotherapy of cancerCancer Immunology, Immunotherapy, 1994
- Idiotype/granulocyte-macrophage colony-stimulating factor fusion protein as a vaccine for B-cell lymphomaNature, 1993
- Suppression of the Immune Response by a Soluble Complement Receptor of B LymphocytesScience, 1991
- Idiotype-anti-idiotype regulation. I. Immunization with a levan-binding myeloma protein leads to the appearance of auto-anti-(anti-idiotype) antibodies and to the activation of silent clones.The Journal of Experimental Medicine, 1981